|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Center Laboratories, Inc. (晟德大药厂)
Main Activities: Chemical Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Center Laboratories, Inc. (晟德大药厂) Headquarters 7F., No.3-2, Yuanqu St., Taipei, Taiwan; New Taipei City; New Taipei City |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: Pyramid & Co., CPAs (2013) Incorporation Date: November 4, 1959 Total Employees: 130 Tel: 886-2-26558680 |
|
Company Description |
| Central Laboratories, Inc. was established in November 1959 as Zhengshi pharmaceutical company and mainly engaged in the production of capsule and tablet formulations. In 1996 the company was renamed as Central Laboratories, Inc. and in October 2003 officially listed in OTC. Among its main products oral liquid accounted for 86% and tablets 13%. Until October 2007 the company has a total of 55 drug licenses, in which oral liquid has 46 licenses. Its main marketing channels include the authorities, | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the first three cumulated quarters of 2012, total net operating revenues decreased with -3.77%, from TWD 423.88 millions to TWD 407.89 millions. Operating Results decreased from TWD 38.76 millions to TWD -12.69 millions. The results of the period reached TWD -11.18 millions at the end of the period against TWD 32.72 millions last year. Return on equity (Net income/Total equity) went from 1.98% to -0.44%, the Return On Asset (Net income / Total Asset) went from 1.73% to -0.39% and the Net Profit Margin (Net Income/Net Sales) went from 7.72% to -2.74% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 14.18% compared to 14.60% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 5.53 to 2.39 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Q3C (non-cons) |
2012 Q2C (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| TW Listed Company Financials | TW Listed Company Financials | |
| ||
| Unit | Millions | Millions |
| ||
Balance Sheet
| ||
Total Assets |
2,879 |
2,046 |
| ||
Current Assets |
769 |
674 |
| ||
Total Liabilities |
357 |
348 |
| ||
Shareholders Equity |
2,522 |
1,697 |
| ||
Current Liabilities |
322 |
315 |
| ||
| * All the accounts are in TWD. | ||
Income Statement
| ||
Total Operating Revenue |
407 |
280 |
| ||
Operational Profit (Loss) |
-12 |
-19 |
| ||
Net Profit (Loss) |
-11 |
-19 |
| ||
| * All the accounts are in TWD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
-0.39% |
-0.95% |
| ||
Annualised Return on Assets (ROA) |
-0.52% |
-1.9% |
| ||
Return on Equity (ROE) |
-0.44% |
-1.15% |
| ||
Annualised Return on Equity (ROE) |
-0.59% |
-2.3% |
| ||
Return on Sales (ROS) |
-2.74% |
-6.95% |
| ||
Return on Capital |
-0.44% |
-1.15% |
| ||
Gross Profit Margin |
46.35% |
47% |
| ||
Operating Profit Margin |
10.68% |
13.09% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
7.99x |
3.84x |
| ||
Inventory Turnover |
5.11x |
3.06x |
| ||
Current asset turnover |
0.53x |
0.42x |
| ||
Fixed-asset turnover |
1.06x |
0.82x |
| ||
Asset Turnover |
0.14x |
0.14x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
-12 |
-19 |
| ||
EBITDA |
1 |
-10 |
| ||
Enterprise value |
3,793 |
3,359 |
| ||
Enterprise Value / EBITDA |
2,257.89 |
-328.70 |
| ||
Bookvalue (BV) |
2,520 |
1,696 |
| ||
Net Cash |
-318 |
-342 |
| Liquidity Ratios | ||
| ||
Current Ratio |
238.96% |
213.78% |
| ||
Quick ratio |
225.65% |
198.39% |
| ||
Doom's day ratio |
12.04% |
2.04% |
| ||
Cash Flow to Debt |
20.82% |
19.03% |
| Leverage Ratios | ||
| ||
Leverage ratio |
114.18% |
120.52% |
| ||
Interest Coverage Ratio |
-386.89% |
-861.57% |
| ||
Debt to equity |
14.18% |
20.52% |
| ||
Debt to total assets |
12.42% |
17.03% |
| ||
Debt / Enterprise Value |
9.43% |
10.37% |
| Market ratios | ||
| ||
Market Cap / Net cash |
-10.90 |
-8.82 |
| Trend Ratios | ||
| ||
Revenue Trend |
96.23% |
89.67% |
| ||
Net Income Trend |
-34.17% |
-73.64% |
| ||
Operating Income Trend |
59.19% |
60.52% |
| ||
 |